Cerus Corporation (CERS)
NASDAQ·Healthcare·Medical - Devices
$1.97
-0.51%
Mkt Cap $380.50M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | $61.83M | $64.60M | +4.48% | -$0.01 | -$0.01 | +0.00% | — | — |
| Q4 2025 Nov 6, 2025 | $59.31M | $52.70M | -11.14% | -$0.02 | -$0.00 | +99.50% | — | — |
| Q3 2025 Aug 5, 2025 | $54.28M | $52.45M | -3.38% | -$0.02 | -$0.03 | -50.00% | — | — |
| Q2 2025 May 1, 2025 | $47.44M | $43.24M | -8.86% | -$0.05 | -$0.04 | +20.00% | — | — |
| Q1 2025 Feb 20, 2025 | $52.95M | $50.81M | -4.05% | -$0.01 | -$0.01 | +0.00% | — | — |
| Q4 2024 Oct 30, 2024 | $50.69M | $46.02M | -9.21% | -$0.01 | -$0.02 | -33.33% | — | — |
| Q3 2024 Aug 1, 2024 | $46.63M | $45.08M | -3.33% | -$0.02 | -$0.03 | -25.00% | — | — |
| Q2 2024 May 2, 2024 | $41.14M | $38.37M | -6.75% | -$0.05 | -$0.05 | -7.14% | — | — |
| Q1 2024 Mar 5, 2024 | $49.27M | $46.77M | -5.08% | -$0.01 | -$0.01 | -58.23% | — | — |
| Q4 2023 Nov 2, 2023 | $51.22M | $39.77M | -22.35% | -$0.05 | -$0.03 | +40.00% | — | — |
| Q3 2023 Aug 2, 2023 | $41.78M | $38.85M | -7.01% | -$0.05 | -$0.07 | -40.00% | — | — |
| Q2 2023 May 4, 2023 | $34.83M | $30.97M | -11.07% | -$0.05 | -$0.09 | -80.00% | — | — |
| Q1 2023 Feb 28, 2023 | $49.16M | $44.03M | -10.43% | -$0.05 | -$0.08 | -68.42% | — | — |
| Q4 2022 Nov 3, 2022 | $46.83M | $39.57M | -15.50% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q3 2022 Aug 4, 2022 | $46.01M | $41.00M | -10.88% | -$0.06 | -$0.05 | +16.67% | — | — |
| Q2 2022 May 5, 2022 | $41.67M | $37.44M | -10.14% | -$0.10 | -$0.07 | +30.00% | — | — |
| Q1 2022 Feb 22, 2022 | $43.90M | $39.87M | -9.18% | -$0.08 | -$0.05 | +37.50% | — | — |
| Q4 2021 Nov 2, 2021 | $37.27M | $36.13M | -3.06% | -$0.10 | -$0.07 | +30.00% | — | — |
| Q3 2021 Aug 3, 2021 | $37.76M | $31.48M | -16.63% | -$0.10 | -$0.09 | +10.00% | — | — |
| Q2 2021 May 4, 2021 | $26.28M | $23.38M | -11.04% | -$0.09 | -$0.10 | -11.11% | — | — |